Neurological complications of HIV infection

Lancet

Volumn 348, Issue 9025, 1996, Pages 445-452

  Price, Richard W ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN TOMOGRAPHY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOENCEPHALOPATHY; LYMPHOMA; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; TOXOPLASMOSIS;

EID: 0030591671     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)11035-6     Document Type: Review

References (50)

1. Price R, Worley J. Management of neurologic complications of HIV-1 infection and AIDS. In: Sande M , Volberding P, eds. The medical management of AIDS. 4th ed. Philadelphia: WB Saunders, 1995: 261-88.
2. Saag MS. Cryptococcosis and other fungal infections (histoplasmosis, coccidioidomycosis). In: Sande M, Volberding PA, eds. The medical management of AIDS. 4th ed. Philadelphia: WB Saunders, 1995: 437-59.
3. Navia B, Petito C, Gold J, et al. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986; 19: 224-38.
4. Hair LS, Nuovo G, Powers JM, Sisti MB, Britton CB, Miller JR. Progressive multifocal leukoencephalopathy in patients with human immunodeficiency virus. Hum Pathol 1992; 23: 663-67.
5. Brew B, Perdices M, Darveniza P, et al. The neurological features of early and "latent" human immunodeficiency virus infection. Aust NZ J Med 1989; 19: 700-05.
6. Berger J, Sheremata W, Resnick L, et al. Multiple sclerosis-like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 1989; 39: 324-29.
7. Brew BJ, Miller J. Human immunodeficiency virus-related headache. Neurology 1993 43: 1098-100.
8. Hollander H, Stringari S. Human immunodeficiency virus-associated meningitis: clinical course and correlations. Am J Med 1987; 83: 813-16.
9. Berger J, Kaszovitz B, Donovan Post M, Dickinson G. Progressive mutifocal leukoencephalopathy in association with human deficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987; 107: 78-87.
10. So Y, Beckstead J, Davis R. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986; 20: 566-72.
11. Holland NR, Power C, Mathews VP, Glass JD , Forman M, McArthur JC. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology 1994; 44: 507-14.
12. Kioumehr F, Dadsetan MR, Rooholamini SA, Au A. Central nervous system tuberculosis: MRI. Neuroradiology 1994; 36: 93-96.
13. Gray F, Belec L, Lescs MC, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994; 117: 987-99.
14. Engstrom J, Lowenstein D, Bredesen D. Cerebral infarctions and transient neurologic deficits associated with acquired immunodeficiency syndrome, Am J Med 1989; 86: 528-32.
15. Post MJ, Hensley GT, Moskowitz LB, Fischl M. Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical, and pathologic correlation. Am J Roentgenol 1986; 146: 1229-34.
16. Cinque P, Vago L, Brytting M, et al. Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid. J Infect Dis 1992; 166: 1408-11.
17. Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Assoc Res Nervous Ment Dis Res Publ 1994; 72: 1-45.
18. Price R. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS 1995; 9 (suppl A): S221-36.
19. Sigurdsson B, Palsson P, Grimson H. Visna, a demyelinating transmissible disease of sheep. J Neuropathol Exp Neurol 1957; 16: 389-403.
20. Price R, Sidtis J. Early HIV infection and the AIDS dementia complex. Neurology 1990; 40: 323-26.
21. Anonymous. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1 ) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778-85.
22. Anonymous. World Health Organization consultation on the neuropsychiatric aspects of HIV-1 infection, Geneva, Jan 11-13, 1990. AIDS 1990; 4: 935-36.
23. Dal Pan G, Glass J, McArthur J. Clinicopathological correlations of HIV-1-associated vacuolar myelopathy: an autopsy-cased case-controlled study. Neurology 1994; 44: 2159-64.
24. Brew BJ, Bhalla RB, Paul M, et al. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS 1992; 6: 461-65.
25. Meillet D, Belec L, Celton N, et al. Intrathecal synthesis of beta 2-microglobulin and lysozyme: differential markers of nervous system involvement in patients infected with human immunodeficiency virus type 1. Eur J Clin Chem Clin Biochem 1993; 31: 609-15.
26. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors: Multicenter AIDS Cohort Study. Neurology 1993; 43: 2245-52.
27. Bacellar H, Munoz A, Miller E, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994; 44: 1892-900.
28. Neaton J, Wentworth D, Rhane F, Hogan C, Abrams DLD. Methods of studying interventions: considerations in choice of a clinical endpoint for AIDS clinical trials. Stat Med 1994; 13: 2107-25.
29. Price R. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex introduction. J Neuro-AIDS 1996; 1: 1-28.
30. Davis L, Hjelle B, Miller V, et al. Early brain invasion in iatrogenic human immunodeficiency virus infection Neurology 1992; 42: 1736-39.
31. O'Brien W. Genetic and biologic basis of HIV-1 neurotropism. In: Price R, Perry S, eds. HIV, AIDS and the brain. New York: Raven, 1994: 47-70.
32. Dickson DW, Lee SC, Hatch W, Mattiace LA, Brosnan CF, Lyman WD. Macrophages and microglia in HIV-related CNS neuropathology. Assoc Res Nervous Ment Dis Res Publ 1994; 72: 99-118.
33. Nuovo G, Gallery F, MacConnel P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am J Pathol 1994; 144: 659-66.
34. Saito Y, Sharer L, Epstein L, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous system tissues. Neurology 1994; 44: 474-81.
35. Lipton SA, Gendelman HE. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332: 934-40.
36. Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol 1993; 33: 343-49.
37. Vago L, Castagna A, Lazzarin A, Trabattoni G, Cinque P, Costanzi G. Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine. J Acquir Immune Defic Syndr 1993; 6: 42-45.
38. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 1992; 10: 685-711.
39. Griffin JW, Wesselingh SL, Griffin DE, Glass JD, McArthur JC. Peripheral nerve disorders in H IV infection: similarities and contrasts with CNS disorders. Assoc Res Nervous Ment Dis Res Publ 1994; 72: 159-82.
40. Tyor WR, Wesselingh SL, Griffen JW, McArthur JC, Griffen DE. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Sybdr Hum Retrovirol 1995; 9: 379-88.
41. Cornblath D, Chaudhry V, Griffin J. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobin. Ann Neurol 1991; 30: 104-06.
42. Said G, Lacroix C, Chemouilli P, et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991 29: 139-46.
43. de Gans, Portegies P, Tiessens G, Troost D, Danner SA, Lange JMA. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. AIDS 1990; 4: 421-24.
44. Roullet E, Assuerus V, Gozlan J, et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 1994; 44: 2174-82.
45. Lipkin W, Parry G, Kiprov D, Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985; 35: 1479-83.
46. Berger AR, Arezzo JC, Schaumburg HH, et al. 2′,3′-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 1993; 43: 358-62.
47. Browne MJ, Mayer KH, Chafee SB, et al. 2′,3′-didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J Infect Dis 1993; 167: 21-29.
48. Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr 1992; 5: 60-64.
49. Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe D. Myopathies associated with human immunodeficiency virus and zidovudine: can their effect be distinguished? Neurology 1993; 43: 971-76.
50. Brew B, Rosenblum M, Cronin K, Price R. The AIDS dementia complex (ADC) and human immunodeficiency virus type 1 (HIV-1) brain infection: clinical virological correlations. Ann Neurol 1995; 38: 563-70.